Showing 1 - 10 of 29
A controversial feature of Medicare Part D is its reliance on private insurers to negotiate drug prices and rebates with retail pharmacies and drug manufacturers. Central to this controversy is whether increases in market power--an undesirable feature in most settings--confer benefits in health...
Persistent link: https://www.econbiz.de/10013156429
Persistent link: https://www.econbiz.de/10003885817
A controversial feature of Medicare Part D is its reliance on private insurers to negotiate drug prices and rebates with retail pharmacies and drug manufacturers. Central to this controversy is whether increases in market power--an undesirable feature in most settings--confer benefits in health...
Persistent link: https://www.econbiz.de/10012463320
Persistent link: https://www.econbiz.de/10003917080
Persistent link: https://www.econbiz.de/10003380907
This study examines the effect of chain store entry on drug quality and prices in the retail pharmacy market in Hyderabad, India. In contrast to prevailing mom-and-pop pharmacies, chains exploit scale economies to offer high-quality drugs at lower cost. With a unique data set and a natural...
Persistent link: https://www.econbiz.de/10013054385
Persistent link: https://www.econbiz.de/10010359989
Persistent link: https://www.econbiz.de/10003770583
Persistent link: https://www.econbiz.de/10012039344
This study examines the effect of chain store entry on drug quality and prices in the retail pharmacy market in Hyderabad, India. In contrast to prevailing mom-and-pop pharmacies, chains exploit scale economies to offer high-quality drugs at lower cost. With a unique data set and a natural...
Persistent link: https://www.econbiz.de/10012458574